Company Name:
affymax_logo.gif
Affymax - Headquarters
Category:
Web Site:
Twitter:
n/a
Company Description:
Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening

Source: CrunchBase


Headquarters: 4001 Miranda Avenue, Palo Alto, CA 94304
37.3996998, -122.13525379999999
Your Connections at Affymax:
Company News (powered by Google News)

Affymax, once a promising biotech, is dissolving - FiercePharma
Posted on Tuesday June 24, 2014

  1. Affymax, once a promising biotech, is dissolving  FiercePharma
  2. Affymax Board Approves Dissolving Troubled Company  Genetic Engineering News
  3. Affymax decides to wind up company following demise of Omontys  The Pharma Letter
  4. Affymax Board Announces Decision to Dissolve the Company  Business Wire
  5. View Full Coverage on Google News


Affymax Crushed After Fatal Drug Recalled; Bleeding Cash, The Company Could Be Done For - Forbes
Posted on Monday February 25, 2013

  1. Affymax Crushed After Fatal Drug Recalled; Bleeding Cash, The Company Could Be Done For  Forbes
  2. Affymax Is Done. RIP.  TheStreet.com
  3. Affymax Reels as Omontys Linked to Five Deaths  Genetic Engineering News
  4. Affymax, Takeda recall anemia drug Omontys after deaths  Reuters
  5. Anemia Drug Recalled After Allergic Reactions; 3 Patients Died  New York Times
  6. View Full Coverage on Google News


Affymax Cuts 230 Jobs, Mulls Bankruptcy, After Drug Withdrawal - Xconomy
Posted on Monday March 18, 2013

Affymax Cuts 230 Jobs, Mulls Bankruptcy, After Drug Withdrawal  Xconomy


Affymax CEO steps down as restructuring firm steps in - San Francisco Business Times - San Francisco Business Times
Posted on Tuesday May 14, 2013

Affymax CEO steps down as restructuring firm steps in - San Francisco Business Times  San Francisco Business Times


Affymax Hires New CEO, Former Genentecher, to Complete FDA Push With Anemia Drug - Xconomy
Posted on Thursday January 06, 2011

Affymax Hires New CEO, Former Genentecher, to Complete FDA Push With Anemia Drug  Xconomy


Affymax Likely Worthless: Omontys Kills At Least 9x More People Than Epogen - Seeking Alpha
Posted on Wednesday August 28, 2013

Affymax Likely Worthless: Omontys Kills At Least 9x More People Than Epogen  Seeking Alpha


Affymax Lives to Fight Another Day, In Bid to Challenge Amgen's Monopoly - Xconomy
Posted on Monday August 09, 2010

Affymax Lives to Fight Another Day, In Bid to Challenge Amgen's Monopoly  Xconomy


Affymax Stock Falls On Unusually High Volume (AFFY) - TheStreet.com
Posted on Tuesday August 09, 2011

Affymax Stock Falls On Unusually High Volume (AFFY)  TheStreet.com


Spero Announces Appointment of Cynthia Smith to its Board of Directors - GlobeNewswire
Posted on Tuesday March 19, 2019

Spero Announces Appointment of Cynthia Smith to its Board of Directors  GlobeNewswire


Amgen Loses Monopoly on Drug for Dialysis Patients - New York Times
Posted on Wednesday March 28, 2012

Amgen Loses Monopoly on Drug for Dialysis Patients  New York Times


Stocks That Hit 52-Week Highs On Thursday - Benzinga
Posted on Thursday January 16, 2020

Stocks That Hit 52-Week Highs On Thursday  Benzinga


Affymax Announces Third Quarter 2012 Financial Results Teleconference and Webcast - Business Wire
Posted on Wednesday October 31, 2012

Affymax Announces Third Quarter 2012 Financial Results Teleconference and Webcast  Business Wire


Alejandro Zaffaroni, Entrepreneur on Biotech Frontier, Dies at 91 - New York Times
Posted on Thursday March 06, 2014

Alejandro Zaffaroni, Entrepreneur on Biotech Frontier, Dies at 91  New York Times


10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook - CNBC.com
Posted on Tuesday November 27, 2012

10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook  CNBC.com


Lawyers Seek to Restore Investors' Losses and Confidence in Affymax, Announces Deans & Lyons Law Firm LLP - Business Wire
Posted on Monday March 11, 2013

Lawyers Seek to Restore Investors' Losses and Confidence in Affymax, Announces Deans & Lyons Law Firm LLP  Business Wire

Videos
map_pin_affymax.png
United States
SF Bay Area
Peninsula
2011-12-27
191
building.png
No
Affymax
No
No
Affymax
Palo Alto
Affymax
affymax
Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening
http://www.crunchbase.com/organization/affymax?&utm_source=odm_csv&utm_medium=export&utm_campaign=dataset
Active
CrunchBase
Affymax
sf-bay-area
company